» Articles » PMID: 21257726

High Prevalence of Vertebral Fractures Despite Normal Bone Mineral Density in Patients with Long-term Controlled Acromegaly

Overview
Specialty Endocrinology
Date 2011 Jan 25
PMID 21257726
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To establish the prevalence of osteoporosis, vertebral fractures (VFs), and non-VFs in acromegaly patients with long-term controlled disease and factors potentially influencing fracture risk.

Design: Case-control study. Patients and measurements Eighty-nine patients (46% male, mean age: 58 years) were included. We studied VFs and non-VFs, bone mineral density (BMD), and markers of bone turnover. In 48 patients, BMD assessment was also obtained 7 years prior to the current study. To compare VF prevalence, data from a sample of the Dutch population (n=3469) were used.

Results: VF prevalence was 59% (men 64% and women 54%), significantly increased when compared with controls (odds ratio up to 6.5), and independent of the duration of disease control, BMD, markers of bone turnover, and acromegalic disease characteristics. Mean number of VFs per patient was 3.4±0.3 (range 1-8). There was no relationship between the number and severity of fractures, parameters of bone turnover, and follow-up BMD measurements. BMD did not change during prolongation of follow-up by 7 years of controlled acromegaly.

Conclusion: There is a very high prevalence of VFs in acromegaly patients with long-term controlled disease, independently of BMD. In view of the significant morbidity and mortality associated with VFs in general and the inability of BMD to predict fracture risk in acromegalic patients, we propose to include VF assessment, for example by lateral conventional radiographs of the spine in the screening of patients with acromegaly, both at diagnosis and during follow-up after establishment of disease control.

Citing Articles

Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly.

Silva F, Lima M, Pedreira C, Matos M J Bone Miner Metab. 2024; .

PMID: 39508862 DOI: 10.1007/s00774-024-01561-z.


Impact of medical therapy for hormone-secreting Pituitary tumors on bone.

Freda P Pituitary. 2024; 27(6):860-873.

PMID: 38967763 DOI: 10.1007/s11102-024-01421-z.


DXA-derived lumbar bone strain index corrected for kyphosis is associated with vertebral fractures and trabecular bone score in acromegaly.

Jaafar S, Cristofolini G, Morenghi E, Rinaudo L, Birtolo M, Sala E Endocrine. 2024; 85(3):1319-1326.

PMID: 38809345 DOI: 10.1007/s12020-024-03863-8.


High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma.

Frara S, Uygur M, Bolamperti F, Di Filippo L, Doga M, Ferrari F Pituitary. 2024; 27(4):370-380.

PMID: 38802688 DOI: 10.1007/s11102-024-01394-z.


Long-term Pegvisomant Therapy of Acromegaly: Effects on Bone Density, Turnover and Microstructure Using HRpQCT.

Kuker A, Agarwal S, Shane E, Bicca J, Geer E, Cremers S J Endocr Soc. 2024; 8(6):bvae079.

PMID: 38715589 PMC: 11074588. DOI: 10.1210/jendso/bvae079.